CLEC-2 depletion by means of an anti-CLEC-2 antibody suppressed experimental hematogenous tumor metastasis and tumor growth, inhibited thrombus formation in the lungs, and improved the outcome in tumor-bearing mice [16]. Here, CLEC1B is linked to neoplasm.